Table 1.
Classes of Nanoparticles for Multimodality Biomedical Imaging and Theragnostics.
| Class | Imaging Modality |
NP Type | Composition | Shape | HD (nm) |
Overall Charge [Core] Surface |
Pros | Cons | Refs. |
|---|---|---|---|---|---|---|---|---|---|
| Inorganic / Organic Hybrid NPs |
MRI / Multimodal Imaging |
MION, CLIO, and SPIO |
Ion oxide with polymer coating |
Globular | 5 - 200 | [None] +, − |
Conventional MRI contrast agents; EPR* |
Interference in imaging; EPR*; difficulty in Rx payload; opsonization; potential toxicity |
7,11,21 |
| Gold Nanorods & Nanoshells |
Gold-containing nanostructures |
Rod or Sphere |
2 - 100 | [None] +, − |
Size tunability; photothermal therapy; sensitivity; NIR; EPR |
67,71-74 | |||
| Optical / Multimodal Imaging |
QDs | Semiconductor core/shell arrays |
Globular | 5 - 50 | [None] +, −, +/- |
Broadband absorption; size tunability; photostability; photoefficiency; targetability |
UV decomposition; aggregation; RES uptake; high potential for toxicity |
8,77-82 | |
| Silica NPs | Ceramic silica photosensitizers |
Globular | 5 - 100 | [None] +, − |
Facile synthesis; solubility; photostability; size tunability; biocompatibility; targetability |
Need contrast agents; aggregation; mechanical stability |
95-97,154 | ||
| Molecular Dots | Calcium phosphate nanocolloids |
Globular | 20 - 100 | [−] +, − |
Facile synthesis; photostability; photoefficiency biodegradability; targetability |
Need contrast agents; EPR; difficulty in Dx and Rx payload |
101,102 | ||
| Multimodal Imaging |
Fullerenes | Carbon- containing hollow structures |
Sphere | 1 - 5 | [None] +, − |
Thermal strength; electrical properties; antimicrobial ability |
Poor water-solubility; aggregation; difficulty in purification, surface modification, and Dx and Rx payload; high potential for toxicity |
55,56,106,15 5 | |
| Carbon Nanotubes |
Carbon- containing tubes |
Cylinder | 3 - 100 | [None] +, − |
Size tunability; mechanical strength; electrical properties |
55,56,106,155 | |||
| Nanoshells and Nanowires |
Metallic semiconductors |
Sphere or Linear |
10 - 300 | [None] +, − |
Size tunability; electrical properties; high-throughput screening; thermal ablation |
108,109,111, 156 | |||
| Organic NPs |
Multimodal Imaging |
Biological NPs | Naturally derived polymers and lipoprotein conjugates |
Linear, Branched, Globular |
10 - 300 | [All] +, −, +/− |
Biocompatibility; flexibility; biodegradability; targetability |
Mechanical weakness; difficulty in size and degradability control |
24,85,116-119 |
| Polymer Nanospheres |
Repeatedly linear or branched units |
Linear or Branched |
1 - 1000 | [All] +, −, +/− |
Biodegradability; flexibility; size tunability; targetability |
Need contrast agents; Dx and Rx payload |
120,123-125 | ||
| Dendrimers | Repeatedly branched macromolecules |
Branched or Globular |
3 - 30 | [All] +, −, +/− |
Hydrophilicity; flexibility; size tunability; targetability; biocompatibility; renal clearance |
Limited synthesis; need contrast agents; Dx and Rx payload |
127-131 | ||
| Liposomes | Phospholipid bilayers |
Spherical | 50 - 1000 |
[All] +, −, +/− |
Conventional drug delivery vehicles; large Dx and Rx payload; EPR |
Need contrast agents; poor stability; EPR; opsonization |
24,51,116,132-136 |
Dx: Diagnostic; EPR: Enhanced permeability and retention; HD: Hydrodynamic diameter; MRI: Magnetic resonance imaging; NIR: Near-infrared; Rx: Therapeutic.
EPR is desired for passive targeting systems, but undesirable for active targeting systems.